IDEAYA Biosciences Market Sentiment

SPY767.68 QQQ737.40−0.95%BTC/USD82,819.00−1.92%DIA515.60−0.37%GLD380.96−3.16%TLT78.78−0.68%

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

$36.69

-0.05-0.14%

At close: Sep 24, 5:00 PM EST

$36.69

-0.05-0.14%

Pre-Market: 5:28 AM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

IDEAYA Biosciences Market Sentiment

Market sentiment signals for IDEAYA Biosciences (IDYA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 12.0% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

—

Avg Consensus PT

$52

+41.2%

Highest Price Target

$79

+115.3%

JP Morgan

Lowest Price Target

$27

-26.4%

Leerink Partners

Short Interest

12.0%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 9, 2026	Guggenheim	Paul Jeng—	+55.4%	$54 → $57	Maintained	Buy
Sep 1, 2026	Citizens	Silvan Turkcan—	+14.5%	$42 → $42	Maintained	Market Outperform
Aug 5, 2026	Truist Securities	Gregory Renza—	+60.8%	$63 → $59	Maintained	Buy
Aug 5, 2026	Wedbush	Robert Driscoll—	+63.5%	$58 → $60	Maintained	Outperform
Jul 7, 2026	RBC Capital	Leonid Timashev—	+30.8%	$53 → $48	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+71.7%	$65 → $63	Maintained	Buy
Jun 12, 2026	Wedbush	Robert Driscoll—	+58.1%	$58 → $58	Maintained	Outperform
Jun 2, 2026	Wedbush	Robert Driscoll—	+58.1%	$58 → $58	Maintained	Outperform
May 7, 2026	Mizuho	Graig Suvannavejh—	+36.3%	$52 → $50	Maintained	Outperform
Apr 14, 2026	Goldman Sachs	Corinne Jenkins—	-4.6%	$31 → $35	Maintained	Neutral
Apr 14, 2026	Wells Fargo	Eva Fortea Verdejo—	+30.8%	$44 → $48	Maintained	Overweight
Apr 14, 2026	RBC Capital	Leonid Timashev—	+44.5%	$49 → $53	Maintained	Outperform
Apr 14, 2026	Wedbush	Robert Driscoll—	+58.1%	$52 → $58	Maintained	Outperform
Apr 14, 2026	Guggenheim	Paul Jeng—	+47.2%	$50 → $54	Maintained	Buy
Mar 31, 2026	Wedbush	Robert Driscoll—	+41.7%	$52 → $52	Maintained	Outperform
Feb 19, 2026	Citigroup	Yigal Nochomovitz—	+77.2%	$64 → $65	Maintained	Buy
Feb 18, 2026	RBC Capital	Leonid Timashev—	+33.6%	$49 → $49	Maintained	Outperform
Feb 18, 2026	Guggenheim	Paul Jeng—	+36.3%	$50 → $50	Maintained	Buy
Feb 18, 2026	Wedbush	Robert Driscoll—	+41.7%	$49 → $52	Maintained	Outperform
Jan 21, 2026	RBC Capital	Leonid Timashev—	+22.6%	$41 → $45	Maintained	Outperform
Jan 7, 2026	UBS	Michael Yee—	+36.3%	$50	Assumes	Buy
Jan 6, 2026	Truist Securities	Gregory Renza—	+63.5%	$59 → $60	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+60.8%	$59	Initiate	Buy
Nov 11, 2025	Mizuho	Graig Suvannavejh—	+25.4%	$44 → $46	Maintained	Outperform
Oct 23, 2025	JP Morgan	Anupam Rama—	+115.3%	$74 → $79	Maintained	Overweight